International Elsevier
Journal
Scientific
Mass Spectrometry and Ion Physics, 45 (1982)
of
Publishing
MASS SPECTROMETRY F.W.
COMBINED
I.J.
McLAFFERTY,
COHEN,
P.O.
Chemistry
Company,
DANIS,
WITH
AMSTER,
G.H.
Dept.,
Amsterdam
MASS SPECTROMETRY M.A.
BALDWIN,
C.J.
KRUPPA,
Cornell
323
323-329 in The Netherlands
- Printed
M.P.
PROCTOR,
University,
BARBALAS,
and
Ithaca,
F.
M.T.
CHENG,
S.L.
TURECEK
NY 14853
USA
ABSTRACT Tandem mass spectrometry (MS/MS) is a rapidly growing field of high promise for structure determination and quantitative analysis because of its sensitivity, specificity and speed. Rapid progress has been made in instrumentation, including the triple quadrupole and tandem double-focusing instruments, automated with on-line computers. Probably the most valuable application to date is the quantitative analysis of targeted compounds at trace levels with high specificity. However, the extra information available from MS/MS appears to be of particular value for the structure determination of large molecules, such as those best ionized by fast atom bombardment.
INTRODUCTION Tandem
can
individual enhance
the
For
the
sequent
former,
be the
gives
of
laboratories For
those
spectrum
from
MS-I
to
GC/MS
from
its
mass
dissociation
by
MS-I.
This
principal
compounds
of
in
areas
of
mixtures
ions
which
and
can
Spectrometry"
by
be
mass
from
used
of
components
for
MS-I
can
of contains
the
can
separation
either
which
so
These
other
their
description 1)
sub-
spectrometry.
leading
in
structural
quantitative
a score
these
MS techniques
and
specific
(ref.
of
mass.
ions
its
all
with
conventional
produced
up-to-date
than
as
a characteristic
primary
for
LC/MS, spectrometry)
species by
the
or
and mass
separated
other of
by more
analysis. the
field descrip-
research
field. structure
sample separated
0020-7381/82/0000-0000/$02.75
most
a detailed
Mass
or
ionized
spectrum
areas
the
the the
of
ions
component in
molecular
from of
mass this
"Tandem
in
(or
data
for
analysis
the is
dissociation
subject
molecular
molecular as
by
interested to
of
produces
of
MS/MS
a second
separated
spectrometry
analogous
mixture
a secondary
referred
utilizes
spectral
spectrum
(chromatography
compound
the
Readers
tions
mass
is
sample
separated
characterization
are
MS/MS method
the
mixture;
MS-II
mass mass
identification
MS/MS
a specific
then
of
1-4)
elucidation.
specific in
primary
quantitative
a separation
Thus,
(ref.
secondary
the
performance
structure
combine
(MS/MS)
measure in
application,
molecular
of
to peaks
analytical
that
spectrometry
(MS-II)
selector of
mass
determination, adduct)
ion
matrix
in
molecular 0 1982
from fast ions Elsevier
impurities atom then
be or
used
bombardment); provides
Scientific
to
anomolous the structural
Publishing
Company
separate peaks
the (such
secondary information.
324
Alternatively, (EI)
the
can
fragment
fragmentation
be
separated
ions
can
in then
spectrum
MS-I, be
and
used
such
secondary
to
as
mass
provide
more
from
electron
spectra
of
detailed
ionization the
separated
information
of
their
structures.
APPLICATIONS
OF MS/MS
Identification
of
Although than
for
components
present
commercial
chromatographic/MS
nesses
are
dentification obvious
one
peak
method
of
many
per
for
components.
for
identification.
valuable by collisionally
to
spectra,
matching
which
their CAD
by
Targeted
analysis
and
are
many
targeted
or
be
or
MS-I
and
sample ticularly
the
5),
of
LC/MS
spectra also
particu-
spectra
for be
this
have
producing
are
mass
can
i-
MS ionization
pro-
qualitatively
CAD
and
this
an without
spectra
are
the
the
produces
find
mass
for
(ref. Mun
and
component
secondary
ions
similar structural
identified
a data
by
base
a PBM search
of
algorithm
laboratory.
to
by
the
can
be
in
complex
both
MS-I
seconds
is
simple
complex
By for
MS-II
can
MS/MS. and
be
primary
from
GC/MS/MS mixtures.
and
ion's (mass
the
chosen,
A key require introduction
sample
fragment
be
selected.
changers
a particular
losses
which
can
usually
automatic
for
knowing
Continuous
containing
neutral
sensitivity
these
separations
fractionation while
very
mixtures.
and
possible,
specific
and
selective
for
Compounds
corresponding
helpful, for
speed,
chromatographic
latter.
Even
promising
for
10T3
samples the
selectivity,
of
conditions
speed;
corresponding
MS-II). probe
peaks is
liquid with
indicated
MS-II
the
references;
compounds ionization
compared
gaseous
interpreting
I.K.
GC/MS
(CAD)
fragment
advantages
sought,
MS/MS
advantageous
and
valuable
mass
of
minutes,
can
Staedeli
EI
in
For
analysis
the.optimum
advantage
been
normal
weakfor
obtained.
to
per
MS/MS
and
favorable
chromatography
peak
or
collected
of
compounds
helpful molecular
be
mixture,
dissociation
against
W.
has
In
expensive
strengths are
difficult
ion
Further,
have
compound MS/MS
the
is
unknown
more
their
can
usually one
CAD spectrum
spectra
implemented
is
least
activated
Unknown
information.
an
is
which
resolution,
it
at
some
duced
in
sufficient
while
produce
larly
-,lOOO
With
ways cases
sensitivities
components
component, can
ions
EI
many
MS/MS
other In
subpicogram
advantage.
which
in
complementary.
technique,
an
instruments
instruments,
surprisingly
particular
of
mixture
are
substructure CAD spectrum
differences
in
between
direct-introduction
LC/MS/MS
appear
to
be
par-
325 GC/MS/MS An
interesting
case
deacetylmetipranolol, metabolite
of
bolite
the
using
could
not
give
Although
MS/MS
the
peak
at
m/r
Ihe
not
266
for
314
to instrument,
267.
higher
additional obviously
was
314 -b 267. than
of
5c
or
3 orders
of
magnitude
at
lo-I1
structure
MS/MS
can
should
sen-
but
a base
the
in m/z
in
complex
to
lo-I1
triple
is
also of
the the
a linear
yielded
at
m/z
quadrupole
can from instrument
reaction
moni-
3081266
over
and
a range
a signal:
of
noise
coefficients
be
the
MS/MS
m/z
with
runs
the
are
produced
response
concentration,
mixture, suf-
by using
"multiple
a
inter-
grams,
the
processes
gives
sample
peaks
the
control
308
reducing
the
achieved
152
studies
Repeat
m/z
C3H6.6~ of
was
Computer
showed
Using
this
of
ratio
variation
be
portant
molecules ions
lationship,
elucidation provide
fragment
the
from ion
spectrum
of by
of
CAD spectra.
primary
mass
of
primary to
the
spectrum this
ion, the
second
fragment mass
and
and
is indicates ion.
ions, elemental
their
those
composition
if
in
the
the
particular whose
of
can
mapping,
found that
Of
im-
molecular
structures
For also
similarly
"Mapping"
indicates
compositions
information,
and
amounts.
spectrum
secondary
the
up
subnonomole
mass
structure
biological
elemental
of
add
molecular
their
primary
composition
in
EI
of larger
their
a larger
pairs
for
only normal
fragmentation
plementary
dimension
valuable
available
while
fragment
a second
unusually
from
characterized
formed
556,
corresponding
between
g.
drug. complexity
better.
Molecular
which
of
energies
these
curve
the
tris-trifluoroacetyl m/z
CAD of
improved
whose
alternating
than
3:l
were
CF3COOH.
A calibration
energy
Quantitation
For
used,
at
sufficiently the
a sufficient
the
peak
components
energies
of
of
MHf
loss
other
collision
advantageous. mode
low
study.
of
not of
of
meta-
detection
+CH2CH(OCOCF3)CH2N(COCF3)CH(CH3)2.
GC/MS/MS
collision
was
because
(CH4)
RNH-CH(CD3)2,
elimination
toring"
better
metabolic
Variation
at
of
using
which
GC provided
a small
this
ion
elimination
capillary
of active
of
multiple
grams,
rearrangement from
derivative,
and
more
the
with
low-level
ionization
MS/MS
noise")
the
hexadeuterio
useful;
quantitation the
sensitive
with
corresponding
limits
the
gives
from
IO-IO
sufficiently
metabolite
peak
setisitivity
of
GC/MS/MS
("chemical
ficient
level
Quantitation
GC/MS
below
Chemical
the 308,
m/z
ference
is
also
quadrupole
unique
low
metipranolol.
study
mixture,
of
a triple
the
capillary
limits
enhancement.
derivative
or
crucial
was
sample
sitivity
involves
drug
column
detection
for
the
6)
'-blocking
packed
sensitive
of
(ref.
(CH,),-phenyl(OH)OCH2CHOHCH2NHCH(CH3)2,
be an
important
secondary
first
ion
can
value
are
com-
masses of
re-
and the
CAD be
elemental
molecular
ion;
326
thus
the
structures
structure are
of
used
those
of
the
to
by
of
that
interpretation
of
electron
the
of through
ion
the
from
5~
-Pregnan-3
unknown
(ref.7).
weight
of
formula
mass
and
exact
and
the
had
evidence
of
proved
very
mass
spectra
and
delineating
the
the
EI
showed
spectrum
and
the
CAD The
tunately
reference
different
5~,3~-, the
strated the
the
m/z
84
peak
hydrogen
of
High
resolution C23H30N20
as
the
unknown
an
MS, and
chemical the
matched
that
of
Djerassi
technically
ionization,
Fortunately
m/z
m/z
information
STIRS
demoof
spectrum this
coworkers drug
of
reciprocal (ref.
9).
attracted overdose
established indicated
234
233,
of
deaths. the
below
molecular in
the for-
CAD spectrum
u-methylfentanyl,
and
and
5u,3u-, of
reference
product
in
to
C rings,
from
implicated
com-
characteristically
the
and
of
C2IH3402,
corresponding and
CAD spectrum
the
give
secondary
ions molecule,
B,
show
the
not
pos-
assignments
stereoisomers the
for by
narcotic
structural
A,
contribution
expected
compound, illicit
a peak
the
the
even been
CAD
5-positions.
give
Self-
could
substituent
of
molecular
However,
odd-electron
structure
I3C
il-
saturated
have
from
that
possible of
the
not
before,
Similarly,
demonstrated This
White.
publicity
this four
be
a molecular
the
would
and
to
5a,36-isomer.
structure
rearrangement
China
for
the
the
the
wide
of the
5;1,30-.
was
not
Comparison
corrected
this
does
corresponds
for
and
CH3COCH$H2+;
former
using
of
total
fragment
the
indicated
the 3-
often
a hypothetical
substituents.
pair
these
fragment
spectrum
prepared
the
e-
is
will
as
indicates
course
confirming at
ions,
indicates
Information
complementary
CAD spectra
unknown, that
formula
of
CI6H260
been
for
C5H80;
fragmentations
5ir.,3ti-, from
helpful
and
ZO-keto
have
used
8)
stereochemistry.
the
spectrum
latter.
never
the
for
corresponding
peak
(ref.
of
frag-
spectra
approaches
been
this
which
stereochemistry
CI5H2502
pOSitiOnS
and
spectra,
the
spectrum this
System
3-hydroxy
reference compounds
unequivocal
of
Retrieval
the
has
of
the
compounds.
mass
measurement
available,
primary CAD
These
steroid
examination
and
against if
mass
Computer
skeleton
sible
This
as
large
of
energy, is
developed
their
fentanye
ionization
internal none
useful,
For
ions
omitting
a quantitative
already
in
molecule. and
is
If be
CAD spectrum
the
fragment
ion's
those
molecules.
steroid
electron
Interpretive
steroid
of to
ion
the
often to
total
spectrum,
sought.
represented the
F -ol-20-one.
C2IH34O2.
matching
of
spectrum
Its
can
of
peices
applications
318,
Training
spectra
examination primary
by
spectra
the
primary
an
of be
similar
substructural
possible
lustrated
CAD mass
such
of
can
indicate
CAD mass
independent spectrum
qualitatively
ionization
lucidation
of The
processes,
structure,
are
can
CAD spectra
energy
reference
rules
together
structures.
low
its
a matching
mentation
The their
formed
characteristic
fragments
molecule.
elucidate
peaks
to
these
bold.
327
CH=CH2
3
However, EI
in
mass
contrast
spectrum
indicates
mary
the
latter
of
the
by
indicate
the
ions abundant
the
the
structures
one
is
ring,
the
Of
which
is
hydrogen,
by
the the
mass
of
first
forms
respectively. should
and
CBHBN+,
completing peak
be
Actually,
ions.
are
CAD spectra
146
pri-
peaks
products
in
m/z
such
The
their
value of
of
CBH50t
and
com-
CHsN=CHCHz,
ionized
particular
confirmed
and
do a molecular
consistent
CAD spectrum
the rule
finding
highest
of
electron"
of
odd-electron
spectrum,
CAD spectrum
"even
C13H16NOt.
to
more
primary
shown.
assignment
piperidine
complementary correspond
EI
the
CHBCH=C=O
these
peaks
dissociation
and
would
containing
in
The
further
example,
of
important
probability
CIBHIgN2+, loss
these
the
For
the
ions. low
from
ions.
producing
even-electron
structure
even-electron
rearrangement
as
above,
a relatively
C16H23N20f,
probability,
relatively
unknown
ions
fragment
reactions
low
be
fragment
represent two
However,
steroid only
will
even-electron spectrum
of
there
pairs
the
the
represent
that
plementary
to
of
with
the
IJ/Z
by
new
110
peak.
High
molecular One
weight
of
application ization these
the
most
to
higher
techniques spectra
compounds
or
no
from
such of
fragment such
such
high
as
as as
ion mass
fast
atom
formed
(M + Na)+
information. ions
to
Lhat
can the
(M + K)+.
weights
above
2000
Fortunately, distinguish
mass
spectrometry
made
possible
(FAB)
(ref.
bombardment
from
and
of
compounds
peaks
those
molecular
areas
weight
anomalous
such
peak,
of
research
molecular
contain
determination, adduct
compounds exciting
be
In
matrix
addition,
daltons
ion
species
ion-
However, structure
or
molecular FAB
provide can
its
for
the
often
CAD spectra molecular
10).
misleading
glycerol
is
be such
ion
spectra little
obtained as
(M + H)+
328
from
adduct
or
characterize
matrix
the
peaks, of
Instrumentation. structed 2.3
at
tesla
10
measurement
of
molecules.
This
precursor Human
Their
CAD
spectra
losses CAD
of
Na
spectrum
to
losses
were
of
found
observation
did
not
amino the
gastrin
ion
Vitamin
abundance is
the
the
ther,
the
lar,
directly
in the
others, ion.
evidence
axial abundant
cobalamin
assignment
that
m/z
from
the
axial 114
chain peak for
is
spectrum
show shows
chain
--m/z 1329°~ethylcobalamin
the 1329
132
CAD
spectrum
to
can is
and
be
have
large
are
a mass
of 971
similar.
with
ex-
m/z
peak of
rela-
the
the
for
loss
cyano.
Fur-
surprisingly losses
is
peaks
of
(HPO3). 57,
these
the
times
that
1270
of
IJ/Z
mass
time
3-10
loss
80
for of
and
the
the
and
confirmed
closely
high
sequential
(sugar),
IJ/~
most
higher,
a very
the
11).
clearly
to
through
and
indicated in
(ref.
is
of
sections but
and
was ions
while
cross
with
1329 corresponds --m/z of IJ/Z 1355, 1329,
+ H),
FAB
from
products,
peaks
CAD spectra
CAD
412
shows
these
results
cholecystokinin
peptide
cleavages
of
the
(M + H)+
their
substantially
no
encouraging
IJ/Z
1404,
and
corresponding
small
cyanocobalmin
first
their Its
that
indicating
the
change The
the
2134.
molecule,
respectively,
1387,
CsI of
spectrum
and
Similar
CAD
12%,
to
(M + Na)+,
peaks
these
mass;
of
the
of
collectible
1368,
H)+,
Particularly
and
spectrum
but
ionization
backbone,
1355,
CAD fragmentation
most
not
FAB.
of
Surprisingly, 2.7%
peaks
to
(dimethylbenzimidazole group
1.6%.
FAB
these
(M + H)+
strong
2.3%
1341,
sample
of
26,
The
of
the
increasing
chain,
1329,
abundances of
with
a FAB 2118,
N-terminus.
for
six
""80%
peaks
sequence
sections
up the
of
with
(M t
spectrum
and
peaks
losses
sequence
bradykinins.
are
side
m/z
FAB
yields yields
B-12.
at
posure
as
three
dissociation
represent
centered
from
C-
10,000
possible
2096,
to
eight
the
CAD cross
seriously
the
peaks
1355
and
shows
both
CAD spectra
Met-Asp-Phe-NH2 from
peak
cm
ions.
IJ/~
intense FAB
spaced
section,
correspond
to
a 60
transmission
produces at
of
up
ion
makes
product
the
ions
sequential
CAD cross
less
to
from
the
regularly 8966)
region
these giving
(M + H)+ acids
decrease
metastable
of
the
contrast
that
tripeptide
tive
of
In
angiotensin,
the
MI
K.
for
peptides,
2096
or
of
(m/z
con-
addition
retain
give
showing
mass
that two
FAB
to
spectrometer the
heptadecapeptide
high
latter
to
collectible
the
indicate the
analysis
high
This
in
with
mass
MS-II
yielding
peaks
(M + K)+,
in
mass
+ ions
unusually
information
11).
potential by
Cs35134
(15-Met).
three
(ref.
improved
the
produced
an
ions
gastrin
only
and
shows '
been
allows
of
fragmentation
ions
accelerating
a CAD spectrum
CS35I34
provide
double-focusing
has
which
' ions csn+lln MS-I analysis
15000.
with
12)
KV ion
to these
tandem
(ref.
magnet
using
efficiency. m/z
The
Cornell MS-I
daltons
and
structures
simiof
146
The
final
-CH(CH3)CH2NH-, at
reference
m/z
914. CAD
The spectra;
329 ACKNOWLEDGMENT
Army
We thank
the
Research
Office,
National Durham
Institutes (Grant
of
Health
G29-79-C-0046)
(Grant for
GM-16609)
and
generous
financial
the
support.
REFERENCES
9 10 11 12
F.W. McLafferty (Ed.), Tandem Mass Spectrometry, John Wiley, New York, 1983. R.W. Kondrat and R.G. Cooks, Anal. Chem., 50, (1978) 81A. R.A. Yost and C.J. Enke, Anal. Chem., 51 (1979) 1251A. F.W. McLafferty, Science, 214, (1981) 280. F.W. McLafferty, A. Hirota, and M. P. Barbalas, Org. Mass Spectrom., 15, (1980) 327. W. J. Richter, W. Blum, U.P.Schlunegger, and M. Senn, ref.1, Chap.21. M.P. Cheng, M.P. Barbalas, R.F. Pegues, and F.W. McLafferty, J. Am. Chem. sot. ) accepted. I.K. Mun, R. Venkataraghavan, and F.W. McLafferty, Anal. Chem., 53, (1981) 179. L. Tokes, R.T. LaLonde, and C. Djerassi, J. Org. Chem., 32 (1967) 1020. M. Barber, R.S. Bordoli, G.J. Elliott, D. Sedgwick, and A.N. Tyler, Anal. Chem., 54 (1982) 645A. I.J. Amster, M.A. Baldwin, M.T. Cheng, C.J. Proctor, and F.W.McLafferty, J. Am. Chem. Sot., submitted. F.W. McLafferty, P.J. Todd, D.C. McGilvery, and M.A. Baldwin, J. Am. Chem. sot. ) 102 (1980) 3360.